Madrigal Pharmaceuticals, Inc. (MDGL)
427.18
+1.97
(+0.46%)
USD |
NASDAQ |
Nov 13, 16:00
427.18
0.00 (0.00%)
After-Hours: 19:59
Madrigal Pharmaceuticals Price to Book Value : 15.82 for Nov. 13, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 12, 2026 | 15.75 |
| November 11, 2026 | 16.04 |
| November 10, 2026 | 16.02 |
| November 09, 2026 | 16.03 |
| November 06, 2026 | 14.80 |
| November 05, 2026 | 14.82 |
| November 04, 2026 | 14.83 |
| November 03, 2026 | 14.68 |
| November 02, 2026 | 15.97 |
| October 30, 2026 | 15.94 |
| October 29, 2026 | 15.99 |
| October 28, 2026 | 15.96 |
| October 27, 2026 | 16.31 |
| October 26, 2026 | 16.21 |
| October 23, 2026 | 16.08 |
| October 22, 2026 | 16.79 |
| October 21, 2026 | 16.96 |
| October 20, 2026 | 17.32 |
| October 19, 2026 | 16.56 |
| October 16, 2026 | 16.66 |
| October 15, 2026 | 17.03 |
| October 14, 2026 | 17.04 |
| October 13, 2026 | 16.75 |
| October 12, 2026 | 17.30 |
| October 09, 2026 | 17.47 |
| Date | Value |
|---|---|
| October 08, 2026 | 17.66 |
| October 07, 2026 | 18.06 |
| October 06, 2026 | 18.39 |
| October 05, 2026 | 18.28 |
| October 02, 2026 | 18.50 |
| October 01, 2026 | 18.51 |
| September 30, 2026 | 18.67 |
| September 29, 2026 | 22.46 |
| September 28, 2026 | 22.80 |
| September 25, 2026 | 22.78 |
| September 24, 2026 | 22.63 |
| September 23, 2026 | 22.62 |
| September 22, 2026 | 22.88 |
| September 21, 2026 | 23.02 |
| September 18, 2026 | 23.44 |
| September 17, 2026 | 23.56 |
| September 16, 2026 | 23.33 |
| September 15, 2026 | 23.07 |
| September 14, 2026 | 23.81 |
| September 11, 2026 | 23.57 |
| September 10, 2026 | 23.51 |
| September 09, 2026 | 24.11 |
| September 08, 2026 | 23.55 |
| September 04, 2026 | 23.86 |
| September 03, 2026 | 23.93 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Insmed, Inc. | 36.59 |
| Alnylam Pharmaceuticals, Inc. | 6.130 |
| Arrowhead Pharmaceuticals, Inc. | 14.48 |
| Cytokinetics, Inc. | -- |
| United Therapeutics Corp. | 3.992 |
Price to Book Value Related Metrics
| PS Ratio | 8.326 |
| Price | 427.18 |
| Earnings Yield | -1.40% |
| Market Cap | 9.920B |